Clinical Trial Update: Effect of Empagliflozin 10 vs 25 mg on LV Remodeling in Diabetic Patients With Anterior STEMI With Reduced LVEF [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating empagliflozin 10 mg vs 25 mg on left ventricular remodeling in diabetic patients with anterior ST-elevation myocardial infarction and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure
• St-elevation Myocardial Infarction

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Ain Shams University | Conditions: Diabete Mellitus, Heart Failure | Phase 2 | Status: COMPLETED